10 Years of Leadless Stimulation in Poland – What Have We Learned?

Le résumé fourni par la source

The article summarises over a decade of experience with leadless pacemaker technology (mainly the MICRA system). Subsequent studies (IDE, PAR, CED) showed a significant reduction in complication rate (up to 48% compared to traditional transvenous cardiac pacing systems) and a high implantation success rate (over 99%). Initially, the available devices offered only the VVI (ventricular stimulation) mode, now MICRA AV models are available for atrioventricular synchronization. Although access through the femoral vein is still the standard, the jugular approach is increasingly used, which is especially beneficial for children, people with “small hearts” heart defects or fragility syndrome. The lack of a subcutaneous pocket and intra-vascular leads minimises the risk of infection, making this technology an excellent alternative for patients after the removal of infected systems. Upcoming innovations such as two- or single- device DDD systems and leadless conduction system pacing will contribute to the further dissemination of this technology and the expansion of its indications.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.